Clever Culture Systems Ltd (ASX: CC5) Share Price and News

Ms Wilson is an experienced company director with private, ASX listed and not-for-profit organisations and has experience leading companies in important commercial activation phases working with CEOs as both an advisor and Non-executive Director to develop and execute effective business strategies that support accelerated and sustained growth. In an executive career that spanned 25 years, Rebecca held global leadership roles in marketing communication, investor relations, ESG, capital management, and corporate affairs. She is also an Independent Non-Executive Director of Not-for-profit Tomisich Foundation and Veski.

Mr Barnes brings a global, company vision and is backing the Company's growth potential. Brent has led the transition of its flagship AI and machine vision technology, APAS, from invention to commercialisation. His focus on global commercial execution is driving sales growth while maintaining the Company's leadership in technology innovation.

Mr Hill has a background working in finance, funds management and private equity. He is an experienced investor and business owner, with a track record of building businesses across industry sectors. With an entrepreneurial mindset, Dan brings a focus on revenue generation to drive the commercialisation and growth of the Company's APAS technology in the pharmaceutical and clinical markets. Dan is an experienced Company Director, having held board and company secretarial positions on a number of public and private companies.

Mr Wisenberg is a professional with over 35 years experience in international business. Born and educated in Cape Town, South Africa, his career has been characterised by an emphasis on business and corporate development, access to capital, and finance. Ian has established himself as a figure in fostering strategic financial partnerships and international relations, aiding companies in accessing global opportunities. Since exiting the full-time operational role at BioCina and Bridgewest, Ian has begun offering support to companies in Australia by leveraging his experience and extensive relationships in the life sciences industry in the United States, Europe and Asia. Ian's career is marked by his skill at forging strategic financial partnerships with an array of institutions. His ability to connect local, national, and international organisations has been a cornerstone of his professional journey. Additionally, Ian has excelled in fostering international relations with both government agencies and private institutions, further amplifying his impact in the global business arena. He has an investor network encompassing Australia, New Zealand, Asia and United States. Ian is Executive Director of Triovance Holdings, LLC, a biotech company based in San Diego and Advisor to BiomeBank, a microbiome platform company based in Adelaide, Australia.

-

-